EMEA-000265-PIP02-11-M02

Key facts

Invented name
Simponi
Active substance
Golimumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0065/2018
PIP number
EMEA-000265-PIP02-11-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of ulcerative colitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Janssen Biologics B.V.
Tel. +31 0715242163
E-mail: ra_office@its.jnj.com; cgram@its.jnj.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating